Medpace Slides 2.84% Ahead of October Earnings Report
The clinical development services provider fell as major indexes rose, with its next earnings report scheduled for October 21.
Makkler Newsroom · Oct 7, 01:44 AM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $674.75 (+3.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO